Search Count: 92
 |
Hiv-1 Wild Type Protease With Grl-072-17A, A Substituted Tetrahydrofuran Derivative Based On Darunavir As P2 Group
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.32 Å Release Date: 2024-07-24 Classification: VIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2024-07-24
 |
Hiv-1 Wild Type Protease With Grl-02519A, With N-(2,5-Dimethylphenyl)-4-(Pyridin-3-Yl)Pyrimidin-2-Amine As P2-P3 Group
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.25 Å Release Date: 2023-05-24 Classification: HYDROLASE/INHIBITOR Ligands: Y9R, NA, CL, ACT, GOL, FMT |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-05-24
Ligands: Y9R, NA, CL, ACT, GOL, FMT
 |
Hiv-1 Wild Type Protease With Grl-03419A, With N-(2,5-Dimethylphenyl)-4-(Pyridin-3-Yl)Pyrimidin-2-Amine As P2-P3 Group And 3,5-Difluorophenylmethyl As The P1 Group
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.12 Å Release Date: 2023-05-24 Classification: HYDROLASE/INHIBITOR |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-05-24
 |
Hiv-1 Wild Type Protease With Grl-110-19A, A Chloroacetamide Derivative Based On Darunavir As P2' Group
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.29 Å Release Date: 2023-02-15 Classification: HYDROLASE/INHIBITOR |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-02-15
 |
Hiv-1 Wild Type Protease With Grl-05816A, With C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2-Ligand [Diastereomer 1]
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.13 Å Release Date: 2022-03-02 Classification: ANTIVIRAL PROTEIN/INHIBITOR |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-03-02
 |
Hiv-1 Wild Type Protease With Grl-01717A, With C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2-Ligand [Diastereomer 2]
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.21 Å Release Date: 2022-03-02 Classification: VIRAL PROTEIN/INHIBITOR |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-03-02
 |
Crystal Structure Of Pseudomonas Aeruginosa D-Arginine Dehydrogenase Y249F Co-Crystallized In The Presence Of D-Arginine
Organism: Pseudomonas aeruginosa (strain atcc 15692 / dsm 22644 / cip 104116 / jcm 14847 / lmg 12228 / 1c / prs 101 / pao1)
Method: X-RAY DIFFRACTION Resolution:1.29 Å Release Date: 2021-12-22 Classification: FLAVOPROTEIN Ligands: 4R2, 6FA, GOL, PEG |
Organism: Pseudomonas aeruginosa (strain atcc 15692 / dsm 22644 / cip 104116 / jcm 14847 / lmg 12228 / 1c / prs 101 / pao1)
Method: X-RAY DIFFRACTION
Release Date: 2021-12-22
Ligands: 4R2, 6FA, GOL, PEG
 |
Crystal Structure Of Hiv-1 Prs17 With Grl-44-10A
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2021-07-28 Classification: HYDROLASE/Inhibitor Ligands: GOL, CL, G04 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: GOL, CL, G04
 |
Crystal Structure Of Hiv-1 Prs17 With Grl-142
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2021-07-28 Classification: HYDROLASE/Inhibitor Ligands: 7OA, GOL, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: 7OA, GOL, CL
 |
Crystal Structure Of Pseudomonas Aeruginosa D-Arginine Dehydrogenase Y249F Variant With 6-Oh-Fad - Green Fraction
Organism: Pseudomonas aeruginosa (strain atcc 15692 / dsm 22644 / cip 104116 / jcm 14847 / lmg 12228 / 1c / prs 101 / pao1)
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2020-07-01 Classification: FLAVOPROTEIN Ligands: 6FA, PEG, GOL |
 |
Crystal Structure Of Pseudomonas Aeruginosa D-Arginine Dehydrogenase Y249F Variant With Fad - Yellow Fraction
Organism: Pseudomonas aeruginosa (strain atcc 15692 / dsm 22644 / cip 104116 / jcm 14847 / lmg 12228 / 1c / prs 101 / pao1)
Method: X-RAY DIFFRACTION Resolution:1.33 Å Release Date: 2020-06-17 Classification: FLAVOPROTEIN, Oxidoreductase Ligands: GOL, FDA |
 |
Hiv-1 Wild Type Protease With Grl-052-16A, A Tricyclic Cyclohexane Fused Tetrahydrofuranofuran (Chf-Thf) Derivative As The P2 Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.25 Å Release Date: 2020-05-13 Classification: ANTIVIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2020-05-13
 |
Hiv-1 Wild Type Protease With Grl-019-17A, A Tricyclic Cyclohexane Fused Tetrahydrofuranofuran (Chf-Thf) Derivative As The P2 Ligand And A Aminobenzothiazole(Abt)-Based P2'-Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2020-05-13 Classification: ANTIVIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2020-05-13
 |
Hiv-1 Protease Multiple Mutant Prs5B With Darunavir
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bru/lai)
Method: X-RAY DIFFRACTION Resolution:1.66 Å Release Date: 2020-04-15 Classification: Hydrolase/Hydrolase Inhibitor, Viral Protein Ligands: PO4, 017 |
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bru/lai)
Method: X-RAY DIFFRACTION
Release Date: 2020-04-15
Ligands: PO4, 017
 |
Hiv-1 Protease Multiple Drug Resistant Mutant Prs5B With Amprenavir
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bru/lai)
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2020-04-15 Classification: Hydrolase/Hydrolase Inhibitor, Viral Protein Ligands: 478, PO4 |
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bru/lai)
Method: X-RAY DIFFRACTION
Release Date: 2020-04-15
Ligands: 478, PO4
 |
Hiv-1 Protease Multiple Drug Resistant Clinical Isolate Mutant Pr20 With Grl-14213A
Organism: Human immunodeficiency virus type 1 group m subtype
Method: X-RAY DIFFRACTION Resolution:1.21 Å Release Date: 2019-09-18 Classification: Hydrolase/Hydrolase Inhibitor Ligands: Y1, 7OA |
Organism: Human immunodeficiency virus type 1 group m subtype
Method: X-RAY DIFFRACTION
Release Date: 2019-09-18
Ligands: Y1, 7OA
 |
Wild-Type Hiv-1 Protease In Complex With A Substrate Analog Ca-P2
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2019-06-19 Classification: HYDROLASE, VIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-06-19
 |
Crystal Structure Of Multi-Drug Resistant Hiv-1 Protease Pr-S17 (D25N)
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.21 Å Release Date: 2019-06-19 Classification: HYDROLASE, Viral Protein Ligands: CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-06-19
Ligands: CL
 |
Crystal Structure Of Multi-Drug Resistant Hiv-1 Protease Pr-S17 With A Substrate Analog P2-Nc In P41
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.71 Å Release Date: 2019-06-19 Classification: HYDROLASE, Viral Protein Ligands: FMT, 2NC |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-06-19
Ligands: FMT, 2NC
 |
Crystal Structure Of Multi-Drug Resistant Hiv-1 Protease Pr-S17 With A Substrate Analog P2-Nc In P61
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2019-06-19 Classification: HYDROLASE, Viral Protein Ligands: 2NC, GOL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-06-19
Ligands: 2NC, GOL